Mirae Asset Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.16%)Nav, as on 21-07-2025

  • Previous Nav

  • Net Change on 21-07-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Mirae Asset Healthcare Fund -Regular Growth 5.65 9.23 14.47 23.28 21.98 21.53
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 14.47 23.28 21.98 1.93 2,785.12
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 12.28 24.18 21.42 1.80 8,569.15
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 19.08 28.73 23.98 1.89 5,727.59
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 19.38 28.02 23.54 1.93 3,849.24
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 13.13 25.62 22.93 1.93 3,056.90
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 11.86 23.79 21.41 2.11 1,281.99

Fund Holdings as on 30-June-2025

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Aurobindo Pharma Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Cipla Ltd.

  • Lupin Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Krishna Institute of Medical Sciences Ltd.

  • Cohance Lifesciences Ltd.

  • Fortis Healthcare Ltd.

  • Aster DM Healthcare Ltd.

  • IPCA Laboratories Ltd.

  • Onesource Specialty Pharma Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Wockhardt Ltd.

  • Alkem Laboratories Ltd.

  • Mankind Pharma Ltd.

  • Gland Pharma Ltd.

  • Sai Life Sciences Ltd.

  • Eris Lifesciences Ltd.

  • TREPS

  • Biocon Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Deepak Nitrite Ltd.

  • Syngene International Ltd.

  • Sagility India Ltd.

  • Laxmi Dental Ltd.

  • Neogen Chemicals Ltd.

  • Laurus Labs Ltd.

  • Zydus Lifesciences Ltd.

  • Mirae Asset Liquid Fund-Direct Plan-Growth

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Chemicals

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Education:B.Com & C.A.
  • Experience:12
  • Basic Details:Mr. Tanmay Mehta has over 12 years of experience primarily into equity research. He has been associated with the AMC since Jan 2021. Prior to this, Mr. Mehta has worked across Institutional Equity Research and Investment Banking Functions at SBI Capital Markets. He is a Chartered Accountant and has also cleared CFA (US).
  • Funds Managed:
  • Mirae Asset Healthcare Fund
  • Mirae Asset Healthcare Fund

  • Cash

  • Equity

  • MFU

View More

About Mirae Asset Healthcare Fund

Scheme Analysis

Mirae Asset Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Mirae Asset Mutual Fund. It was launched on 02-Jul-2018 and currently has an AUM of ₹2,785.12 crore. Mirae Asset Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of Mirae Asset Healthcare Fund ended down ₹-0.06(-0.16%)yesterday to ₹39.475.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The Mirae Asset Healthcare Fund is managed by Vrijesh Kasera and Tanmay Mehta.

Fund House Contact

Unit 606, 6th Floor, Windsor Building, Off CST Road, Kalina, Santacruz (E), Mumbai - 400 098

022-67800300
022-67253940